AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

High-flow Nasal Cannula Versus Conventional Oxygen During Awake Tracheal Intubation With Difficult Airways

RecruitingNAAges 18 Years - anyAllWenxian Li
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

Study Background Airway management is one of the most fundamental and critical technical procedures in anesthesiology, critical care, and emergency medicine. Difficult airway management remains a major challenge in these fields, particularly when a "cannot intubate, cannot ventilate" scenario occurs during the induction of general anesthesia. Such events can rapidly lead to hypoxemia, resulting in brain injury or even death, and have become a significant source of anesthesia-related severe complications and medical disputes. Awake tracheal intubation (ATI) is considered the gold standard for airway management in patients with anticipated difficult airways, as it preserves spontaneous breathing and thereby reduces the risk of catastrophic airway failure during anesthesia induction. However, despite routine supplemental oxygen administration, hypoxemia remains one of the most common and p

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: * Presence of an anticipated difficult airway; * Planned awake tracheal intubation; * Age โ‰ฅ 18 years; * Willingness to participate in the study and provision of written informed consent. Exclusion Criteria: * Contraindications to HFNC use, such as severe nasal obstruction or deformity, recent (within 3 months) nasal or skull base surgery, skull base fracture, or active epistaxis; * Hemodynamic instability, defined as a mean arterial pressure (MAP) \< 65 mmHg or the need for vasoactive medications to maintain blood pressure; * Pregnancy; * Current participation in another interventional clinical trial.
๐Ÿ’Š

What it tests

  • High-Flow Nasal Cannula
  • Ligh-Flow Nasal Cannula
๐Ÿ“

Where

6 sites
Wuwei People's Hospital
Wuwei, China
South China Hospital of Shenzhen University
Shenzhen, China
Baoding No.1 Central Hospital
Baoding, China
Pizhou Hospital of Traditional Chinese Medicine
Pizhou, China
Eye & ENT Hospital of Fudan University
Shanghai, China
The First People's Hospital of Neijiang
Neijiang, China
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy